DOCSLIB.ORG

~Ttpk\. ' INIS-Mf —127V3 Department of Nuclear Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
~Ttpk\. ' INIS-Mf —127V3 Department of Nuclear Medicine ~TTPk\. ' INIS-mf —127V3 Department of nuclear Medicine UNIVERSITY OF THE WITWATERSRAT1D, JOHANNESBURG MESSAGE FROM THE CONGRESS CONVENORS What an exciting time it has been! The committee with whom we have been working have applied themselves to the unique task of organising a congress in the Kruger National Park. Indeed, from the moment the suggestion to have a congress in the Park was made, the committee suddenly galvanised into action, and this resulted in this most spectacular undertaking. The 1990 Nuclear Medicine Congress coincides with the great universal ecological awakening for the last decade of this millenium. It is therefore fitting that the Congress should be held in such a beautiful conservationist setting. While South Africa undoubtedly is equal to the rest of the world in its medical investigation and treatment of disease it still has a tremendous amount to learn from international experts such as are gathering for the Congress. We thank all the speakers both international and local for their willingness to participate. We would like to pay tribute, and thank all those who have given time and effort unstintingly towards the realisation of this creative Congress. PROF. J. LEVIN PROF. J.D. ESSER SUMMARIZED PROGRAMME Wednesday 12th September 1990 12h00 - 18hOO Registration 18hOO Congress Opening Chris Jansen Memorial Lecture Cocktail Party Thursday 13th September 1990 06h00 Game Drives O9hOO - 12h15 Academic Sessions 13h30 - 14h00 Meeting of Nuclear Medicine Physicians 14h00 - 16h30 Academic Sessions 17h00 Wine Tasting and Game Drives 19hOO Bosveld Braai 20h30 Guest Lecture Friday 14th September 1990 06h00 Game Drives 09hOO - 14h30 Academic Sessions 15h00 - 16hOO Meeting of S.A. Society of Nuclear Medicine 16h30 Game Drives 18h00 Congress Closing 19h00 Spit Braai CONGRESS COMMITTEE CONGRESS JOANI LANDMAN CO-ORDINATOR (ELSCINT) SECRETARY BELINDA HO (ELSCINT) SOCIAL PROGRAMME ELSA SPRINGOLO CO-ORDINATOR POSTER TREVOR MDAKA CO-ORDINATOR CONGRESS BOB VALLEY CONSULTANT MARIE LAVSON ROTH WINTERTON AVRIL SLAVIN ACADEMIC SUB—COMMITTEE CONVENOR DR A MCKNIGHT PROF J ESSER PROF J LEVIN PHYSICS PROF M LSTTER EXECUTIVE COMMITTEE 1989/9O SOUTH AFRICAN SOCIETY OF NUCLEAR MEDICINE PRESIDENT PROF J KLOPPER SECRETARY/ PROF A OTTO TREASURER PROF M L8TTER PROF J ESSER MRS M MEAD OUR SINCERE THANKS TO Poster Prize NUCNEVS Quiz Prizes ELSCINT Cocktail Party ELSCINT Administration ELSCINT Registration NEDFIN BANK Dinner INVESTEC BANK Braai Evening SIEMENS/ AGFA Congress Bags PROTEA OLD MUTUAL FOR THEIR GENEROUS FINANCIAL ASSISTANCE ATOMIC ENERGY CORPORATION WEIL ORGANIZATION ELSCINT S.A. PHILLIPS LIST OF EXHIBITORS AGFA A.E.C ELSCINT FRANSA INVESTEC BANK NEDFIN BANK PNI SCIENTIFIC SIEMENS PERITECH GUEST HOUSES ELSCINT SIEMENS AGFA PROTEA SOPHA MEDITEK OBITUARY: DR A J VAN WYK With the demise of Dr Adriaan (Andre) Jakobus van Wyk on the 1st September 1989 in Switzerland, South Africa lost on of its' leaders in the field of radiopharmacy. Dr van Wyk was a member of the SA Society of Nuclear Medicine, the SA Chemical Institute and the SA Association of Physicists in Medicine and Biology. He was also registered as a scientist with the SA Council of Natural Scientists. He joined the AEC during July 1974 and for 15 years played a leading role in the development and establishment of Tc-99m labelling kits and I-131-labelled compounds which are used in most of the South African Nuclear Medicine Departments. He was known internationally having presented various papers at International Conferences and a score of publications in International Journals. His contribution in the field of Nuclear Medicine included the publishing of various articles on new radiopharmaceuticals. The articles dealt with important new agents to study renal and hepatobiliary function; brain and cardiac perfusion and phaeochromocytoma. During the early eighties he made a very important contribution to Nuclear Medicine by the introduction of a unique process for the local production of I-131-labelled MIBG to be used for the diagnosis and therapy of phaeochromocytomas. Andre van Wyk was a beloved and respected colleague who made a permanent impression on all who knew him with his thoroughness and dedication. His contribution to the advancement of nuclear medicine in South Africa will always be remembered. DR P J Fourie Head: Isotope Production Centre Atomic Energy Corporation Pelindaba The Society of Nuclear Medicine would like to pay tribute to their colleague, Dr Adriaan Jakobus van Wyk and honour his memory. S A SOCIETY OF NUCLEAR MEDICINE FOURTH CONGRESS R O G R A M M WEDNESDAY 12TH SEPTEMBER 199O 1 8 H O O — Prof. J Esser- W e 1 come EVENING — Prof. P van Heerden Opening Address — Prof. M LQtter C2ir±s Jansen Memorial L e c t xi T e THURSDAY 13TH SEPTEMBER 199O SESSION I NEUROLOGY O9hOO-lOh3O CHAIRMEN: Professors V Fritz & W—D Heiss f ' / Flow determination by SPECT and PET : A Comparative study in cerebrovascular disease - W-D Heiss The use of PIRACETAM in the treatment of acute stroke: Comparison of two imaging methods, SPECT and CAT scanning - R Winterton. V Fritz, J Esser, A Ming, S Hinton PET of FDG for the evaluation of PIRACETAM effects in dementia - W-D Heiss HMPA0-Tc99m scintigraphy in dementia: initial evaluation of a 3-dimensional representation - J Dobbelaere, L Kiebooos, L Diieskens, M Segers, E Bergen 10h30 — llhOO — TEA SESSION II CARDIOLOGY HhOO — 12hl5 CHAIRMEN: Professors K 1 o p p e v Otto A comparison of the Clinical relevance of 201 Thallium and Tc99m MIBI for the evaluation of myocardial blood flow CP Herbst, H Theron, A van Aswegen. PHT Kleynhans, AC Otto, MG Letter Differences in the amount of myocardium in jeopardy between silent and symptomatic ischaemia - AG Digenio, J Esser, DR Mavunda, AJ Dalby, G Rogers MIBI - The Tygerberg experience - A Ellmann, W Hauser, P Erlank MIBI and the Q-tfave - W Hauser, JF Klopper. A Ellmann. P Erlank 1 2H1 5 3H3 O LUNCH 1 3H3 O — 1AHOO — A s s o c ± a. t ± o n of Nuclear Med±c±ne PtiysiciansT Meeting SESS I ON III MONOCLONAL ANTIBODIES 14hOO — 15hOO CHAIRMEN: Professor E s s v a n Heexrden Tc99M antibodies : One-step labelling method for use in imaging - BA Rhodes Tc99m labelling of nonspecific, polyclonal human immunoglobulin - WKALouw, CM Potgieter, PJ Fourie Treatme-rft of metastaMrtt" colorectal cancer/by means of specific monoclonaj/antibodies conjugat>d^with 1-131 : a pha'Se II study T^P Riva, G Mo-sifatslli, V Tison, P M^rigi Monoclonal Antibody Imaging, clinical and technical perspectives - I Garty, AN Serafini, GN Sfakianakis 15HOO — 15H3O — TEA SESS ION I V ENDOCRINE 5 ti3O — 16h3O CHAIRMEN: Dr B Shu1kin & Professor J Lev±n Demonstration that bone mass is increased in black prepubertal and early pubertal children - L Gordon, NH Bell, J Shary, J Stevens, M Garza, J Edwards The role of thyroid scintigraphy in the surgery of thyroid disease - A Mannell, A McKnight Pentavalent Tc99m (v) DMSA Scintigraphy in medullary carcinoma of the thyroid - BK Adams, MJ Byrne, NS Levitt PET Scanning with Cll hydroxyephedrine for the characterisation of neuroendocrine tumours - BL Shulkin, DM Wieland, M Schwaiger, MS Haka, KC Rosenspire, B Shapiro EVENING •From atoms to I m a. g ± n. g : A philatelistic journey' — Professor A Dubb FRIDAY 1-4TH SEPTEMBER 199O jar************************* SESSION V POSTERS: SECTIONS 1. 2, 3 O9HOO — 1OH3O SECT I ON 1 CHAIRMEN: Professor I Dormetil & I> v C Herbst Platelet kinetics under normal and septic shock conditions in a baboon model - IC Dormehl, M Maree, J Kilian, L Jacobs Tumour size dependent changes in a CaNT tumour: use of in vivo H - 1 NMR for non-invasive evaluation of Tl and T2 time relaxation - D Szeinfeld, N de Villiers, S Wynchank Regulatory requirements for the sale and distribution of radiopharmaceuticals in South Africa - OE Forsyth, PJ Fourie A Comparison of red cell labelling methods - SM Rubow, P Erlank. E Pieterse, JF Klopper Tumour damage in Rhabdomyosarcoma after exposure to different doses of neutrons - D Szeinfeld, N de Villiers, G Overy, S Wynchank Imaging of inflammatory lesions with Tc-99m HMPAO labelled granulocytes - AC Otto, M Dunn, A Krieger, et al The excretion of pertechnetate in milk - SM Rubow. WP Baard, M van Niekerk The triolein breath test: A useful test in the evaluation of malabsorption - S Naidoo, A Manohar, AE Houlder, M Chetty, LJ Den Hartog Neutrophil kinetics in normal and septic shock conditions - M Maree, IC Dormehl, D Cromarty, H Bockman, L Jacobs, Radioisotope production at the national accelerator centre: I. Bombardment facilities and procedures - SJ Mills, FJ Haasbroek, FM Nortier, WL Rautenbach, HA Smit, CJ Stevens Radioisotope production at the national accelerator centre: II. Chemical and radiopharmaceutical facilities and procedures - D du T Rossouw, P Andersen, A Chippendale, S Dolley, AR Eatwell. FJ Haasbroek, SJ Mills, C Naidoo, TFHF van Elst The effects of Nisoldipine on left ventricular filling rate in patients with ischaemic heart disease measured with radionuclide gated blood pool scintigraphy - AC Otto, A van Aswegen, CP Herbst, MA Sweetlove, AC Viviers, GR Flint SECTION 2 CHAIRMEN: Professor R Keddy & Dr H Wasserman Production of Thailium-201 from a Thallium cyclotron target - AR Eatwell , FJ Haasbroek, FM Nortier The selection of a mathematical model for the calculation of the mean red cell survival time - MG Lotter, WL Rabe, JAH de Lange, H Naude, PN Badenhorst, A du P Heyns, AC Otto, B Meyer Scintigraphic dynamic tomography: How it works - AJ White, WJG Pilloy, B Scheffer A Baboon model for in vivo assessment of mucociliary lung clearance - N Hugo, L Jacobs, IC Dormehl, G Ras, M Maree Determination of lung volumes by nuclear medicine techniques - RP Clauss, W Pilloy The assessment of mucocil1iary clearance using monodisperse 99mTc-tagged red blood cells - UM Botha, WJ Strydom. HD Brandt.
Load more

Recommended publications
  • Celebrating 20 Years of SPECT/CT the Introduction of Hawkeye, the World’S First Hybrid Imaging System
    CLINICAL VALUE HAWKEYE SPECT/CT Celebrating 20 Years of SPECT/CT The introduction of Hawkeye, the world’s first hybrid imaging system Nearly 20 years ago, a pivotal event shaped the future of The unclear medicine nuclear medicine. Once called the “unclear medicine,” nuclear Invented by Hal O. Anger in the mid-1950s, nuclear medicine medicine was forever changed with the introduction of cameras detect gamma radiation to depict metabolic Hawkeye, the world’s first clinical hybrid imaging system. processes within a living body. While gamma cameras helped GE Healthcare (at that time known as GE Medical Systems) revolutionize the field of functional medical imaging, there was introduced Hawkeye, a dual-modality SPECT and CT system, at one key limitation: the lack of anatomical markers in the image. the 1999 Society of Nuclear Medicine (SNM) Annual Meeting, heralding in a new era of “more clear medicine.” “We always understood that we needed anatomical and structural data to provide the best details and a precise answer to the clinical question,” says Ora Israel, MD, Director Emeritus of Nuclear Medicine/PET (retired) at Rambam Healthcare Campus, Haifa, Israel. She recalls using fiducial markers placed on the patient’s body to identify the location of key anatomical areas, such as the chest or abdomen. In some cases, Professor Israel and her colleagues would try to repeat the nuclear medicine study on a CT with the patient in the same position. It was a difficult and time-consuming process that she says never really worked well. “There was a clear purpose to improve the specificity of nuclear medicine by defining the anatomical relationship between isotope imaging and anatomy,” says Martin Sandler, MD, Professor of Radiology and Radiological Sciences and formerly Chairman of the Department of Radiology and Radiological Sciences at Vanderbilt University School of Medicine.
    [Show full text]
  • Foreign Private Issuers Lists, 1996
    u.s. Securities and Exchange Commission FOREIGN COMPANIES REGISTERED AND REPORTING WITH THE u.S. SECURITIES AND EXCHANGE COMMISSION DECEMBER 31 , 1996 Office of International Corporate Finance Division of Corporation Finance REPORTING FOREIGN ISSUERS AS OF DECEMBER 31, 1996 SUMMARY"INFORMATION REPORTING COUNTRY COMPANIES CANADA 374 UNITED KINGDOM 81 ISRAEL 71 MEXICO 30 NETHERLANDS 29 AUSTRALIA 26 BERMUDA 22 CHILE 22 JAPAN 21 FRANCE 18 ITALY 13 ARGENTINA 12 BRITISH VIRGIN ISLANDS 11 IRELAND 11 SWEDEN 10 INDONESIA 9 GERMANY 8 LUXEMBOURG 8 SPAIN 8 NETHERLANDS ANTILLES 7 NORWAY 7 BAHAMAS 6 SOUTH AFRICA 6 CHINA 5 FINLAND 5 HONG KONG 5 LIBERIA 5 BRAZIL 4 CAYMAN ISLANDS 4 COLOMBIA 4 DENMARK 4 KOREA 4 NEW ZEALAND 4 VENEZUELA 4 PERU 3 PORTUGAL 3 SINGAPORE 3 BELGIUM 2 PANAMA 2 PHILIPPINES 2 BELIZE 1 BOTSWANA 1 GHANA 1 PAPUA NEW Gl.!lNEA 1 RUSSIA 1 SWITZERLAND 1 TAIWAN 1 ZAMBIA 1 TOTAL 881 p MARKET SUMMARY BY COUNTRY NASDAQ NASDAQ COUNTRY NYSE AMEX NMS Small Cap OTC COMBINED ARGENTINA 10 0 1 0 1 12 26 AUSTRALIA 9 0 7 3 7 BAHAMAS 1 0 2 0 3 6 BELGIUM 0 0 2 0 0 2 BELIZE 0 0 1 0 0 1 BERMUDA 9 3 7 1 2 22 BOTSWANA 0 0 0 0 1 1 4 BRAZIL 2 0 1 0 1 BRIT. V.1. 0 0 8 1 2 11 CANADA 61 39 94 57 123 374 CAYMAN ISLANDS 0 2 2 0 0 4 CHILE 19 0 1 0 2 22 CHINA 5 0 0 0 0 5 COLOMBIA 2 0 0 0 2 4 DENMARK 3 0 1 0 0 4 FINLAND 3 '0 0 1 1 5 FRANCE 9 0 6 0 3 18 GERMANY 5 0 1 0 2 8 GHANA 1 0 0 0 0 1 HONG KONG 1 0 0 0 4 5 0 4 9 I INDONESIA 4 0 1 IRELAND 5 0 3 1 2 11 ISRAEL 4 5 45 11 6 71 ITALY 11 0 2 0 0 13 JAPAN 11 0 7 1 2 21 KOREA 3 0 0 0 1 4 LIBERIA 2 2 0 0 1 5 LUXEMBOURG 3 0 5 0 0 8 MEXICO 25 2 0 0 3 30 NETH.
    [Show full text]
  • ISRAEL Global Center for Breakthrough
    ISRAEL Global Center for Breakthrough www.investinisrael.gov.il Bright Source Dear Reader, Israel is recognized as being Israel’s ability to continuously produce high- at the forefront of high- quality innovative products is fundamental to tech innovation, backed by a its capacity to compete globally and the Israeli highly educated and creative government considers it a high priority to ensure workforce and a sound and support Israel’s future competitiveness. infrastructure. Some of the I am confident that the vitality of the Israeli market world’s largest multinational will continue to position it as a global destination corporations developed their for foreign investment and invite you to take part key breakthroughs in Israel, in our future expansion. and the ongoing influx of new companies serve as a sign of the vibrancy of Israel’s industrial research and development. Israel enjoys the highest percentage in the world Sincerely, of engineers in the workforce and one of the Binyamin (Fouad) Ben Eliezer – highest ratios of university degrees and academic publications per capita. Israel’s finest innovations were developed through the combination of necessity, proven problem solving skills and creativity. Due to the close-knit web of Israeli society, the synergetic nature of Israeli industry Minister of Industry, Trade and Labor allows for cross-sectoral adaptations of technology from the security sector to life sciences, IT and communications. Highly trained graduates of the IDF applied cutting edge defense technology to market-changing civilian applications. 3 Intel Dear Investor, Israeli Innovations Israel has a long track record of An ability to quickly respond to market demands market-creating, profit driving and identify future needs as well as to determine Merging Necessity & Ingenuity Striving for SUCCESS breakthrough innovations and provide solutions to global needs across which have positively impacted different sectors; The technological skill of Israeli life worldwide.
    [Show full text]
  • Development of Computed Tomography
    Case Histories of Significant Medical Advances: Development of Computed Tomography Amar Bhidé Srikant Datar Katherine Stebbins Working Paper 20-004 Case Histories of Significant Medical Advances: Development of Computed Tomography Amar Bhidé Harvard Business School Srikant Datar Harvard Business School Katherine Stebbins Harvard Business School Working Paper 20-004 Copyright © 2019, 2020, 2021 by Amar Bhidé and Srikant Datar Working papers are in draft form. This working paper is distributed for purposes of comment and discussion only. It may not be reproduced without permission of the copyright holder. Copies of working papers are available from the author. Case Histories of Significant Medical Advances Development of Computed Tomography Amar Bhidé, Harvard Business School Srikant Datar, Harvard Business School Katherine Stebbins, Harvard Business School Abstract: We describe how Computed Tomography (CT) scanners - that combine x-rays and computers to image soft tissues of the brain and other organs -- have become a widely used diagnostic tool. Specifically, we chronicle the: 1) the initial development of CT technology and markets (in the 1960s and 1970s); 2) Broadening of uses and users (in the 1980s); and 3) introduction and adoption of combination scanners (in the 1990s). Note: This case history, like the others in this series, is included in a list compiled by Victor Fuchs and Harold Sox (2001) of technologies produced (or significantly advanced) between 1975 and 2000 that internists in the United States said had had a major impact on patient care. The case histories focus on advances in the 20th century (i.e., before this millennium) in the United States, Europe, and Japan -- to the degree information was available to the researchers.
    [Show full text]
  • Israel's High-Tech Figures
    High-Tech Industries Israel’s High-Tech Figures Israel has become one of the world’s most highly regarded and 2001. He joined the company in 1994, and is serving as a director important high-tech centers and high-tech is the main growth in some of Elron's subsidiaries. engine of Israel’s economy. In 2004, Israeli high-tech sales exceeded $15 billion, including $12.9 billion in exports. In the Davidi Gilo – One of the most important inventors and peak year of 2000, no less than 3,000 high-tech start-ups were entrepreneurs of the Israeli high-tech industry. Gilo is also the active in Israel – one start-up per 2,000 residents. man responsible for one of biggest high-tech deals in Israeli history – the purchase of DSPC (DSP Communications), a This chapter presents the figures standing behind the impressive wireless communications chip designer, by Intel (1999), in a deal activities of Israel’s high-tech industries. Israel’s high-tech worth $1.6 billion. community is characterized by a high concentration of talent, Gilo established the DSPC Group in the United States, but its energy and innovation. We’ve chosen to focus on a number R&D centers were located in Israel. of issues important to Israeli high-tech, featuring some of the personalities. Benny Peled (deceased) – Major General (Res.) Benny Peled, former Commander of the Israeli Air Force (1973-1977), Founding Fathers served as president of Elbit and its subsidiary Elscint. Peled turned Elbit into one of the most important providers of defense Efi Arazi – The “wonder kid” of the Israeli economy, is best systems and equipment in Israel and abroad.
    [Show full text]
  • INVESTOR PRESENTATION March 2021 This Presentation Is for Information Purposes Only
    ELRON - INVESTOR PRESENTATION March 2021 This presentation is for information purposes only. By this presentation, Elron does not intend to solicit offers to purchase its securities and the presentation does not constitute an invitation to receive such offers, and nothing said therein constitutes a “public offering”, as defined in the Israel Securities Law, 5728-1968. Elron may make improvements and/or changes in the features or content presented herein at any time. Elron shall not be liable for COMMENTS any loss, claim, liability or damage of any kind resulting from the investor's reliance on or reference to any detail, fact or opinion presented herein. The presentation is not intended to provide a comprehensive description of Elron's activities, and Elron urges investors to consider the information presented herein in conjunction with its public filings including its annual and other periodic reports. Nothing in this presentation should be considered "investment advice", as defined in the Israel Regulation of Investment Advice, Investment Marketing and Portfolio Management Law, 5755-1995. Certain statements made over the course of this presentation may be forward-looking in nature, as defined in Section 32A of the Israel Securities Law, 5728-1968. Such forward-looking statements involve known and unknown risks, uncertainties, forecasts, assessments, estimates or other information, which relates to a future event or matter whose occurrence is not certain and which is not within the sole control of Elron, and other factors which may cause the actual results, performance and achievements of Elron to be materially different from any future results, performance and achievements implied by such forward-looking statements.
    [Show full text]
  • Compugen: Rising Bioinformatics Star
    October 2000 No. 53 The #1 investment newsletter on Israeli technology companies Compugen: Rising bioinformatics star Compugen Ltd. analysis and modeling processes. Its technologies $ Nasdaq enable scientists to accelerate their research efforts (based on daily closing prices) in discovery of drugs, therapeutics, diagnostics and 20 agricultural products. 18 The field of predicting biological processes through 16 the use of mathematics has generated intense 14 interest, particularly since the advent of the Human 12 Genome Project, which created huge amounts of raw genomic and other data. The underlying biology is 10 IPO price complex, and the data are relatively unorganized, rife with errors, overlaps, duplication and missing pieces. Trading Volume, in millions These factors have made Genome Project data 0.6 exceedingly difficult to analyze. 0.4 But the potential for using this data is immense 0.2 since many human diseases are related to inadequate or poorly performing proteins. Aug 15 Sept 1 Sept 15 Thousands of additional drug targets and possible Traded: Nasdaq Symbol: CGEN cures for diseases, rather than just treatments, may Recent Price: $14 1/16 be identified through a better understanding of how 2000 High - Low: $19 1/2 - $10 1/16 proteins are regulated, inhibited or stimulated and Initial Offering Price: $10 the genetic content of cells. Shares Offered: 5,000,000 continued on page 2 Shares Outstanding: 25,975,581 Market Capitalization: $365 million In This Issue... Formed in 1993, Compugen has made a name for Compugen: Rising bioinformatics star 1 itself as a pioneer in combining advanced The Market 4 computational techniques and molecular biology.
    [Show full text]
  • The Helix Model of Innovation in Israel
    THE HEBREW UNIVERSITY OF JERUSALEM Department of Sociology and Anthropology The Helix Model of Innovation in Israel: The Institutional and Relational Landscape of Israel’s Innovation Economy Prof. Gili S. Drori (editor) Ohad Barkai Amy Ben-Dor Navah Berger Alexandr Bucevschi Noga Caspi Avida Netivi With Prof. Henry Etzkowitz תשע"ג – 2013 Jerusalem, Israel E-2 | The Helix Model of Innovation in Israel Table of Content Preface E-7 1. Prof. Gili S. Drori Helix model of innovation in Israel: The global scheme and its local application E-9 2. Prof. Henry Etzkowitz Israel’s innovation system: A triple helix with four sub-helices E-39 3. Alexandr Bucevschi Industry Patent applications and the quadruple helix: Mapping connections in Israeli industry E-47 4. Navah Berger University Case study of the seven research universities’ technology transfer offices in Israel E-71 5. Amy Ben-Dor Government Feminist Discourse and Supporting Technology Innovation with Triple Helix Model Abstract E-101 6. Noga Caspi Civil Society Ashoka-Israel as an advocate of social entrepreneurship: A case of civil society impact on innovation and entrepreneurship in Israel Abstract E-103 | E- 3 7. Ohad Barkai Financial Sector The Israeli field of research funding: Implication for the helix model Abstract E-105 8. Avida Netivi Military “Talpiyot” project as a security triple helix Abstract E-107 E-4 | The Helix Model of Innovation in Israel | E- 5 Authors’ Biographies Ohad Barkai is a BA graduate of the Sociology and Anthropology Department, The Hebrew University of Jerusalem. He is currently employed as a QA engineer at FundTech Ltd.
    [Show full text]
  • EFSUMB History of Ultrasound Israel
    EFSUMB HoUS Israel 3/19/2021 / 10:30 1 EFSUMB History of Ultrasound Editor: Christoph F. Dietrich Israel Liat Appelbaum1, Diana Gaitini2, Yakov Itzchak3, Nira Beck-Razi4 1Director, Unit of Ultrasound, Department of Radiology, Hadassah Medical Center, Jerusalem, Israel 2Clinical Professor Emeritus, Rambam Medical Center and Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel 3Professor Emeritus, Faculty of Medicine, Tel Aviv University, Israel 4Director, Unit of Ultrasound, Department of Radiology, Rambam Medical Center, Haifa, Israel Corresponding author: Liat Appelbaum Unit of Ultrasound, Department of Radiology, Hadassah Medical Center, Jerusalem, Israel [email protected] Acknowledgment: We acknowledge the Israel Ultrasound pioneers, founders of the Israel Society of Ultrasound EFSUMB HoUS Israel 3/19/2021 / 10:30 2 The Israel Society of Ultrasound in Medicine The Israel Society of Ultrasound in Medicine (ISDUM) was founded 36 years ago (1984) by three local pioneers in Ultrasound: Prof. Y. Yitzchak, Prof. J. K. Kaftori and Dr. H. Zackut, with the collaboration of Prof. Barry Goldberg, Head of the Ultrasound unit at the Thomas Jefferson University Hospital in Philadelphia, USA. The new Society was integrated in the frame of the Israel Radiological Society (ISRA), joining the disciplines involved in the practice of Ultrasound in Medicine. ISRA was founded in 1927, 21 years before the establishment of the State of Israel (1). Diagnostic ultrasound both in Israel and abroad is divided into four main categories: Obstetrics/Gynecology, Vascular, Echocardiography, and Abdominal/General. At the beginning, ISDUM included both General and Obstetrics/Gynecology Ultrasound. Later on, the Israel Society of Ultrasound in Obstetrics and Gynecology was founded and split off from the original Ultrasound Society.
    [Show full text]
  • SIEMENS Head-To-Head, Nobodyoutperforms Siemens
    SIEMENS Head-to-head, nobodyoutperforms Siemens. “I@ieusedmanydifferentbrandsof nuclear imagingequipment,but noneliveup to Siemens.―—NuclearPtrysician “inthisday and age,you need theirkind of stabillty.―—ChiefTechnologist ‘Serviceis a Siemenshigh point. lt@one of the mainreasons @ebuy theirnuclear medicineequipment.―—Administrator Leadershiptechnology.Rock-solidreliability. Servicethat keepsuptimeup. Thesedoctors and administratorsare all talkingaboutone thing: valuein nuclearmedicineequipment. And theyfind it all in one company:Siemens. Simplyput, peopledependon our equipment. The new IntegratedDIACAM@Systemcon thues to setthe standard.And our second generationMULTISPECT@Systemsextendthat reputation.Featureslikethe revolutionaryICON@ interfacebring interactiveeaseand flexibilityto nuclearstudiesAndthenewIntegratedConsole savesthetwothingsmostvaluablein a nuclear department—spaceand time. _____ Advancedfeatures,sensible designs,continuousimprove- I ments At Siemens,we use our headsto keep you aheadin nuclear medk@ina SiemensMedical Systems,Inc. 2501North BarringtonRoad HoffmanEstates,IL 60195 Telephone:708-304-7252 Siemens... technologyin caringhands. I @ @.: Freedom of choice begins here I, -@ “liii' andhere. (. ‘A U For all the thyroid uptake tests you need to handle quickly and accurately, there's really only one system capable of being compared to our computer-based, Capintec System1000.It's our fast,accurate and economical CAPTUS 500.Both feature on-screen prompts and spectrums, hard-copy printouts, and with
    [Show full text]
  • Nanox Imaging: Company Perspectives and Short-Sellers Allegations
    Nanox Imaging: Company Perspectives and Short-sellers Allegations DEEP KNOWLEDGE ANALYTICS December 2020 Introduction Introduction 3 Disclaimer: Our research institute does not have any direct or indirect Nanox Vision - About Company 4 relations with any of the parties mentioned in this document, including but not limited to, Nanox imaging ltd., any of its employees, affiliates, directors, Technical Characteristics of the Product 7 partners, founders or suppliers. We do not hold any NNOX shares, either Main Partners and Customers 13 directly or indirectly and have no options, warrants, long or short positions in NNOX equities or its derivatives. Our research is an independent review Market Analysis 16 with no financial or other benefits to be derived from its publication. The information and opinions in this report were prepared by us as an Market Perspectives 17 independent organization. Though the information herein is believed to be Up to date Customers 19 reliable and has been obtained from public sources believed to be reliable, we make no representation as to its accuracy or completeness. Hyperlinks Investors and Investments 22 to third-party websites in this report are provided for reader convenience Investments History 26 only. We neither endorse the content nor are responsible for the accuracy or security controls of these websites. This report is provided on an Team Analysis 27 independent basis and should not be deemed as a recommendation to buy C-Level Analysis 28 or sell NNOX stock. R&D Team 29 IP Analysis 31 Patents Overview 33 Conclusions 36 CONTACT US Prototype Demonstration 38 www.dka.global Comparative Analysis (SWOT Analysis) 39 [email protected] Disclaimer 41 Executive Summary The report presents an independent analysis of the business and Nanox Imaging is currently without a commercially available prototype technological prospects of Nanox Imaging Ltd.
    [Show full text]
  • BEIC-Austria-Entrepreneurship at Israel and Technion Oct-2010
    Israel A start-up nation 1 Israel (2009) 7.4 mln inhabitants Technion GDP $ 195 bln (Estimate) GDP per capita $ 26,351 Source TAMAT University of Haifa 100 km Bar-Ilan University Tel-Aviv University Weizmann Institute of Science The Hebrew University of Jerusalem • 24 incubators • over 2000 start-ups • over 80 VC/PE’s Ben-Gurion University • 68 companies on Nasdaq • leading multinationals • matured Israeli high tech including service providers 2 MBA-Entrepreneurship-2010 • Office of Chief Scientist2 Phases in Israel’s economic development 1948-1968 • Export mainly agriculture • Building the science based capabilities: - Technion 1924 - Hebrew University 1925 - Weitzman Institute 1934 • Innovations and entrepreneurship in Agriculture (Kibbutz) and the Defense area 3 Phases in Israel’s economic development 1969-1992 • Arms embargo after six day war in 1967 • Building defense-industry-university complex - 65% of R&D defense related - Defense as % of GDP grew to 25% in 1980 - Indigenous industry for planes, tanks, electronics warfare • Spin-offs from defense e.g. Elscint, Scitex, Orbotech • Multinationals entering Israel (e.g. Intel, Motorola) • Due to historical labor-socialist tradition deep antagonism toward individual entrepreneurship • Establishment of Office of Chief Scientist in 1968 4 Phases in Israel’s economic development 1993-2010 • 1993 tipping point for take-off of high-tech sector • High-tech, now already 34% of industry, drives growth • Tech-entrepreneurs are the new heroes 5 The Hi-Tech Growth in Israel New High-Tech VC/PE raised in Companies Mln dollars average per year average per year From 1969- 1992 7 7 From 1993-2005 307 1,214 6 Today: The Second Silicon Valley Nr.
    [Show full text]